#Sarepta_Therapeutics
LightNews LightNews
newsen.bsky.social
Investigation Launched into Sarepta Therapeutics Officers Amid Safety Concerns#United_States#New_Orleans#Kahn_Swick#Sarepta_Therapeutics#ELEVIDYS
Investigation Launched into Sarepta Therapeutics Officers Amid Safety Concerns
Kahn Swick & Foti has started investigating Sarepta Therapeutics' leadership due to serious safety allegations involving Elevidys treatment.
third-news.com
September 5, 2026 at 2:06 AM
newsen.bsky.social
Pomerantz Law Firm Probes Sarepta Therapeutics for Potential Investor Claims#United_States#New_York#Securities_Fraud#Pomerantz_LLP#Sarepta_Therapeutics
Pomerantz Law Firm Probes Sarepta Therapeutics for Potential Investor Claims
Pomerantz LLP is investigating claims against Sarepta Therapeutics, uncovering potential securities fraud and uncovering investors' rights for compensation.
third-news.com
November 20, 2025 at 4:38 PM
newsen.bsky.social
Kuehn Law Alert for Sarepta Therapeutics Investors: Important Steps to Take#USA#New_York#Kuehn_Law#Sarepta_Therapeutics#ELEVIDYS
Kuehn Law Alert for Sarepta Therapeutics Investors: Important Steps to Take
Kuehn Law is investigating potential breaches by Sarepta Therapeutics officers that may impact investors. Learn how to protect your rights today.
third-news.com
September 24, 2025 at 6:11 PM
newsen.bsky.social
Elanco Animal Health Joins S&P MidCap 400; Sarepta Enters S&P SmallCap 600#United_States#New_York#Elanco_Animal_Health#Sarepta_Therapeutics#Berkshire_Hills_Bancorp
Elanco Animal Health Joins S&P MidCap 400; Sarepta Enters S&P SmallCap 600
Elanco Animal Health will replace Sarepta Therapeutics in the S&P MidCap 400, reflecting strategic shifts within major stock indices effective September 2, 2025.
third-news.com
August 26, 2025 at 10:22 PM
newsen.bsky.social
Class Action Lawsuit Filed Against Sarepta Therapeutics, Inc. for Investor Recovery#United_States#New_York#Gross_Law_Firm#Sarepta_Therapeutics#SRPT
Class Action Lawsuit Filed Against Sarepta Therapeutics, Inc. for Investor Recovery
The Gross Law Firm announces a class action lawsuit against Sarepta Therapeutics, urging shareholders to register. Possible recovery awaits investors deceived by misleading statements.
third-news.com
August 25, 2025 at 12:53 PM
newsen.bsky.social
Investors Target Sarepta Therapeutics in Fraud Class Action Lawsuit with Schall Law Firm#USA#Los_Angeles#Schall_Law_Firm#Securities_Fraud#Sarepta_Therapeutics
Investors Target Sarepta Therapeutics in Fraud Class Action Lawsuit with Schall Law Firm
Sarepta Therapeutics faces a class action lawsuit for alleged securities fraud. Schall Law Firm calls for affected investors to join before the deadline.
third-news.com
August 25, 2025 at 7:22 AM
newsen.bsky.social
Sarepta Therapeutics Investors Encouraged to Join Class Action Lawsuit#USA#DJS_Law_Group#Eastchester#Sarepta_Therapeutics#ELEVIDYS
Sarepta Therapeutics Investors Encouraged to Join Class Action Lawsuit
Investors affected by Sarepta Therapeutics, Inc.'s alleged misleading statements about its ELEVIDYS therapy are urged to join a class action lawsuit before the deadline.
third-news.com
August 25, 2025 at 7:21 AM
newsen.bsky.social
Sarepta Therapeutics Investors Encouraged to Join Securities Fraud Lawsuit Amid $100K Losses#United_States#New_York#Rosen_Law_Firm#stock_fraud#Sarepta_Therapeutics
Sarepta Therapeutics Investors Encouraged to Join Securities Fraud Lawsuit Amid $100K Losses
Investors holding Sarepta Therapeutics securities with losses over $100K from 2023-2025 are urged to join a fraud lawsuit by August 25, 2025.
third-news.com
August 22, 2025 at 7:03 PM
newsen.bsky.social
Sarepta Therapeutics Investors Urged to Act Before Class Action Deadline#United_States#San_Diego#Class_Action#Investor_Alert#Sarepta_Therapeutics
Sarepta Therapeutics Investors Urged to Act Before Class Action Deadline
Investors of Sarepta Therapeutics with significant losses face a crucial deadline to join a class action lawsuit. Immediate action is needed.
third-news.com
August 22, 2025 at 6:06 PM
newsen.bsky.social
Pomerantz Law Firm Issues Investor Alert on Sarepta Therapeutics Class Action Lawsuit#United_States#New_York#Pomerantz_Law_Firm#Sarepta_Therapeutics#ELEVIDYS
Pomerantz Law Firm Issues Investor Alert on Sarepta Therapeutics Class Action Lawsuit
The Pomerantz Law Firm has announced a class action lawsuit against Sarepta Therapeutics due to concerns over potential securities fraud and their drug, ELEVIDYS.
third-news.com
August 22, 2025 at 2:14 PM
newsen.bsky.social
Faruqi & Faruqi, LLP Launches Investigation Against Sarepta Therapeutics Investors#USA#New_York#Faruqi_&_Faruqi#Investors_Rights#Sarepta_Therapeutics
Faruqi & Faruqi, LLP Launches Investigation Against Sarepta Therapeutics Investors
Faruqi & Faruqi, LLP is investigating potential securities claims against Sarepta Therapeutics. Investors who have suffered losses can learn their rights.
third-news.com
August 22, 2025 at 1:53 PM
newsen.bsky.social
Sarepta Therapeutics Investors Urged to Join Class Action Lawsuit for Securities Fraud#United_States#New_York#Class_Action#Sarepta_Therapeutics#ELEVIDYS
Sarepta Therapeutics Investors Urged to Join Class Action Lawsuit for Securities Fraud
Sarepta Therapeutics investors are notified of a pending class action lawsuit. Claims are focusing on alleged securities fraud related to their gene therapy product ELEVIDYS.
third-news.com
August 22, 2025 at 12:47 PM
newsen.bsky.social
Investors with Losses in Sarepta Therapeutics Have Class Action Lawsuit Opportunity#USA#San_Diego#Class_Action#Sarepta_Therapeutics#SRPT
Investors with Losses in Sarepta Therapeutics Have Class Action Lawsuit Opportunity
Investors in Sarepta Therapeutics, Inc. can lead a class action lawsuit following significant losses related to securities. Deadline is August 25, 2025.
third-news.com
August 21, 2025 at 8:40 PM
newsen.bsky.social
Shareholders Urged to Join Class Action Against Sarepta Therapeutics by August 25, 2025#United_States#New_York#Class_Action#Gross_Law_Firm#Sarepta_Therapeutics
Shareholders Urged to Join Class Action Against Sarepta Therapeutics by August 25, 2025
A new class action has been filed against Sarepta Therapeutics, urging affected shareholders to join by the deadline of August 25, 2025. Act now for potential recovery.
third-news.com
August 21, 2025 at 1:15 PM
newsen.bsky.social
Investors Invited to Lead Class Action Suit Against Sarepta Therapeutics with Schall Law Firm#United_States#Los_Angeles#Schall_Law_Firm#Sarepta_Therapeutics#ELEVIDYS_therapy
Investors Invited to Lead Class Action Suit Against Sarepta Therapeutics with Schall Law Firm
Sarepta Therapeutics faces a class action lawsuit for false statements regarding its ELEVIDYS therapy. Discover your rights as an investor.
third-news.com
August 21, 2025 at 9:07 AM
newsen.bsky.social
Sarepta Therapeutics Shareholders Can Lead a Class Action Lawsuit with DJS Law Group#USA#DJS_Law_Group#Eastchester#Sarepta_Therapeutics#SRPT
Sarepta Therapeutics Shareholders Can Lead a Class Action Lawsuit with DJS Law Group
Sarepta Therapeutics shareholders are urged to join a class action lawsuit concerning alleged securities violations. DJS Law Group is available to assist before the deadline.
third-news.com
August 21, 2025 at 8:00 AM
newsen.bsky.social
Investors Urged to Join Class Action Against Sarepta Therapeutics for Alleged Securities Fraud#USA#New_York#Levi_&_Korsinsky#Sarepta_Therapeutics#ELEVIDYS
Investors Urged to Join Class Action Against Sarepta Therapeutics for Alleged Securities Fraud
Investors who faced losses in Sarepta Therapeutics due to alleged securities fraud are encouraged to join a class action lawsuit led by Levi & Korsinsky.
third-news.com
August 19, 2025 at 1:39 PM
newsen.bsky.social
Sarepta Therapeutics Shareholders Urged to Join Class Action Lawsuit After Sectioned Allegations#United_States#New_York#Securities_Class_Action#Sarepta_Therapeutics#ELEVIDYS_therapy
Sarepta Therapeutics Shareholders Urged to Join Class Action Lawsuit After Sectioned Allegations
Sarepta Therapeutics shareholders are encouraged to join a class action lawsuit due to allegations of misleading statements surrounding ELEVIDYS gene therapy. Act by August 25, 2025.
third-news.com
August 18, 2025 at 1:05 PM
newsen.bsky.social
Investors Encouraged to Join Sarepta Therapeutics' Class Action Lawsuit with Schall Law Firm#USA#Los_Angeles#Schall_Law_Firm#Securities_Fraud#Sarepta_Therapeutics
Investors Encouraged to Join Sarepta Therapeutics' Class Action Lawsuit with Schall Law Firm
Sarepta Therapeutics faces a class action lawsuit regarding alleged securities fraud. Investors can participate and recover losses before August 25, 2025.
third-news.com
August 18, 2025 at 12:14 PM
newsen.bsky.social
Sarepta Therapeutics Investors Invited to Join Class Action Lawsuit Over Securities Violations#United_States#DJS_Law_Group#Eastchester#Sarepta_Therapeutics#SRPT
Sarepta Therapeutics Investors Invited to Join Class Action Lawsuit Over Securities Violations
Sarepta Therapeutics investors facing losses can join a class action lawsuit for alleged violations of securities laws. Contact DJS Law Group before August 25, 2025.
third-news.com
August 18, 2025 at 6:42 AM
newsen.bsky.social
Sarepta Therapeutics Faces Class Action Lawsuit Over Alleged Securities Fraud and Investor Losses#USA#New_York#Pomerantz_LLP#Sarepta_Therapeutics#ELEVIDYS
Sarepta Therapeutics Faces Class Action Lawsuit Over Alleged Securities Fraud and Investor Losses
Pomerantz LLP has initiated a class action against Sarepta Therapeutics amid serious investor concerns following the tragic outcomes linked to its product ELEVIDYS.
third-news.com
August 16, 2025 at 2:39 PM
newsen.bsky.social
Important Update for Sarepta Therapeutics Investors Regarding Potential Claims Before August 2025#USA#New_York#Levi_&_Korsinsky#Sarepta_Therapeutics#SRPT
Important Update for Sarepta Therapeutics Investors Regarding Potential Claims Before August 2025
Investors in Sarepta Therapeutics, Inc. are urged to reach out to Levi & Korsinsky by August 25, 2025, to discuss their rights regarding a class action lawsuit.
third-news.com
August 15, 2025 at 1:28 PM
newsen.bsky.social
Legal Inquiry Into Sarepta Therapeutics Amid Serious Safety Concerns#United_States#New_York#Faruqi_&_Faruqi#SEC_Investigations#Sarepta_Therapeutics
Legal Inquiry Into Sarepta Therapeutics Amid Serious Safety Concerns
Faruqi & Faruqi is probing potential legal claims against Sarepta Therapeutics due to alarming safety issues with its treatment ELEVIDYS, affecting investors.
third-news.com
August 14, 2025 at 4:23 PM
newsen.bsky.social
Important Deadline for Sarepta Therapeutics, Inc. Investors Approaching Soon#United_States#New_York#Gross_Law_Firm#Sarepta_Therapeutics#SRPT
Important Deadline for Sarepta Therapeutics, Inc. Investors Approaching Soon
Sarepta Therapeutics investors are urged to contact The Gross Law Firm before August 25, 2025, regarding potential legal rights and opportunities.
third-news.com
August 14, 2025 at 1:12 PM
newsen.bsky.social
Levi & Korsinsky Alerts Sarepta Therapeutics Investors About Class Action Deadline#USA#New_York#Levi_&_Korsinsky#Sarepta_Therapeutics#SRPT
Levi & Korsinsky Alerts Sarepta Therapeutics Investors About Class Action Deadline
Sarepta Therapeutics investors are urged by Levi & Korsinsky to take action before the August 25, 2025, deadline regarding a class action lawsuit addressing securities fraud allegations.
third-news.com
August 12, 2025 at 2:47 PM